Pediatric Asthma Case Study

Introduction

Asthma remains the most common chronic respiratory disorder in childhood and is a leading cause of emergency visits and hospital admissions worldwide. A pediatric asthma case study helps clinicians and students integrate theory with practice by examining a real‑world scenario, analyzing pathophysiology, identifying risk factors and evaluating evidence‑based interventions. According to StatPearls, asthma is a chronic inflammatory disease characterized by episodes of airflow obstruction due to airway edema, bronchospasm and mucous hyper‑secretion[1]. Episodes of cough, wheezing, chest tightness and shortness of breath may vary in frequency and severity, but uncontrolled disease can lead to respiratory failure and death[1]. The case study also underscores the importance of an integrated care pathway and self‑management skills; poor asthma control can impair lung development and quality of life[2].

A pediatric asthma case study provides a structured method for analyzing clinical problems. It bridges the gap between guidelines and bedside management and trains nurses in comprehensive assessment, critical thinking and holistic care. Asthma’s multifactorial etiology involves genetic predisposition, environmental exposures and socio‑economic factors[3]. Prevalence varies by age, gender, race, ethnicity and socio‑economic status[4]. Case‑based learning allows practitioners to recognise risk factors, triggers and co‑morbidities, thereby improving early diagnosis and treatment. It also highlights challenges in current pediatric asthma care, such as fragmented services and inadequate follow‑up. A recent qualitative study found that general practitioners often focus on treating acute symptoms and underestimate chronic management, leading to over‑ or undertreatment[2]. Lack of established follow‑up structures and variable engagement in shared decision‑making contribute to poor self‑management skills among patients and their families[2]. Examining a case therefore offers insight into how nurses can advocate for coordinated care and empower families.

Epidemiology and Risk Factors

The prevalence of childhood asthma has plateaued since 2009 but remains high in certain subgroups. In the United States, approximately 7.8 % of children suffer from asthma[5]. Boys are more commonly affected than girls in childhood, whereas the pattern reverses after puberty[6]. African‑American and Hispanic children experience higher prevalence rates compared with Caucasian or non‑Hispanic peers[7]. Low socio‑economic status and living in urban, high‑pollution areas also increase risk[8]. Family history, prenatal exposures (maternal smoking, viral infections), obesity, premature birth and early allergen exposure further predispose children to asthma[3]. Recognizing these factors helps clinicians focus on prevention and early intervention.

Pathophysiology of Pediatric Asthma

Asthma is characterized by chronic airway inflammation, bronchial hyper‑responsiveness and episodic airflow obstruction. In susceptible children, environmental or endogenous triggers (allergens, viral infections, exercise, cold air, air pollutants or stress) activate inflammatory pathways within the airway mucosa. Mast cells release histamine and leukotrienes; eosinophils and neutrophils contribute to airway edema and mucous production. Smooth muscle contraction leads to bronchospasm and narrowing of the lumen. The degree of reversibility can vary; without prompt treatment, airway remodeling may occur, leading to persistent symptoms and loss of lung function. StatPearls notes that asthma symptoms often worsen at night and may be triggered by upper respiratory tract infections, exercise, exposure to tobacco smoke, dust or allergens[9]. Accurate diagnosis requires clinical history and, in children over five, spirometry to assess airflow limitation and bronchodilator responsiveness[10].

Case Presentation

Patient Profile

Patient: “A.G.” is a 10‑year‑old boy who presents to the emergency department (ED) with worsening shortness of breath, wheezing and cough. He has a history of mild persistent asthma diagnosed at age six, triggered mainly by seasonal pollen and viral infections. His family reports frequent missed school days over the past month due to coughing at night. They previously attended an outpatient clinic but have not had a follow‑up in over a year because of relocation. His mother notes that she stopped filling his inhaled corticosteroid prescription several months ago because “he seemed fine.”

Past Medical History: Diagnosed with asthma at age six; one prior ED visit for asthma exacerbation at age seven. Known allergies to dust mites and cat dander. No history of intubation. Up to date on immunizations.

Family History: Mother has allergic rhinitis and eczema; an older sibling has asthma. There is a paternal history of smoking.

Medications: Intermittent albuterol metered‑dose inhaler (MDI) with a spacer; no controller medication for the past 3 months.

Social History: Lives in a rented apartment in an urban area with visible mold in the bathroom. Exposed to second‑hand tobacco smoke when visiting relatives. Physical activity limited due to symptoms; misses after‑school sports.

Presenting Complaint: Two days prior, A.G. developed rhinorrhea and low‑grade fever. He started coughing more frequently, especially at night. On the day of presentation, he experienced increased shortness of breath and wheezing, unresponsive to two at‑home albuterol treatments. His mother describes the breathing as “fast and laboured,” and he had difficulty speaking in full sentences.

Physical Examination

On arrival, A.G. is alert but anxious, sitting upright and leaning forward. Vital signs are as follows:

• Temperature: 37.8 °C
• Heart rate: 125 beats per minute (tachycardia)
• Respiratory rate: 32 breaths per minute (tachypnea)
• Blood pressure: 110/70 mm Hg
• Oxygen saturation: 91 % on room air

Inspection reveals subcostal and intercostal retractions and nasal flaring. Auscultation shows diffuse expiratory wheezes with prolonged expiratory phase, decreased air entry at the lung bases and occasional inspiratory wheeze. No crackles are heard. He is unable to speak more than four or five words without pausing for breath. Capillary refill is 2 seconds; extremities are warm. No cyanosis is present. A.G. appears anxious and is clutching his chest; he is aware of his condition and expresses fear of suffocating.

Initial Assessment and Diagnostic Workup

Severity Assessment: A rapid severity assessment is essential for acute exacerbations[11]. A.G.’s clinical presentation tachypnea, tachycardia, oxygen saturation of 91 %, marked wheezing, use of accessory muscles and impaired speech indicates a moderate to severe exacerbation. The presence of retractions and anxiety suggests increased work of breathing.

Peak Flow Measurement: A peak expiratory flow (PEF) measurement with a portable peak flow meter is attempted. A.G.’s PEF is 200 L/min, which is 60 % of his personal best. This value supports the moderate to severe classification.

Continuous Pulse Oximetry: Continuous monitoring is initiated. Pulse oximetry is recommended in acute episodes to ensure oxygen saturation remains ≥92 %[12].

Blood Gases: An arterial blood gas (ABG) analysis reveals mild hypoxemia (PaO₂ 65 mm Hg), and PaCO₂ is 35 mm Hg (normocapnia), reflecting increased respiratory effort with adequate ventilation.

Chest Radiograph: Routine chest X‑rays are not always necessary; they are reserved for cases where pneumonia or pneumothorax is suspected. In A.G.’s case, his presentation is classic for an asthma attack without focal findings, so radiography is deferred.

Laboratory Tests: A complete blood count (CBC) reveals mild leukocytosis (WBC 11 × 10⁹/L) with a slight eosinophilia. Serum potassium is normal. Beta‑agonists may cause hypokalemia, so serial potassium levels will be monitored[13].

Nursing Diagnoses

Based on the data collected, the following nursing diagnoses are identified:

1. Ineffective breathing pattern related to bronchospasm and airway obstruction as evidenced by tachypnea, use of accessory muscles and dyspnea[1].
2. Ineffective airway clearance related to mucosal edema and increased mucus production, as evidenced by wheezing and reduced air entry[1].
3. Anxiety related to breathlessness and fear of suffocation, as manifested by restlessness and statements of fear[14].
4. Deficient knowledge regarding asthma triggers, medication adherence and self‑management, evidenced by inconsistent use of controller medication and exposure to triggers[2].
5. Risk for caregiver role strain related to inadequate follow‑up and difficulty managing chronic disease, as manifested by the mother’s report of missing appointments.

Evidence‑Based Management of Acute Exacerbation

Effective management of a pediatric asthma exacerbation involves prompt assessment, rapid initiation of therapy and frequent reassessment. A.G.’s treatment plan follows recommendations from the Canadian Pediatric Society and the National Asthma Education and Prevention Program (NAEPP). The management includes airway maintenance, oxygen therapy, bronchodilation, systemic steroids, and escalation of care when necessary.

Airway and Oxygen Therapy

Ensuring a patent airway and adequate oxygenation is the first priority. Supplemental oxygen should be administered when oxygen saturation falls below 92 %[12]. A.G. receives humidified oxygen via nasal cannula at 2 L/min, which increases his oxygen saturation to 95 %. Continuous oximetry is maintained.

Bronchodilators

Short‑Acting Beta₂‑Agonists (SABA): Salbutamol (albuterol) is the bronchodilator of choice for acute exacerbations[15]. An MDI with a spacer delivers the drug efficiently and reduces side effects[16]. A.G. receives 5 mg of nebulized salbutamol mixed with 0.5 mg ipratropium bromide via face mask. Nebulized therapy is used initially because of his moderate distress and difficulty with MDI technique. The combination of a beta₂‑agonist with an inhaled anticholinergic (ipratropium) improves lung function and reduces hospital admissions in moderate‑to‑severe crises[17]. The dose is repeated every 20 minutes for the first hour while monitoring heart rate and respiratory effort.

Ipratropium Bromide: Ipratropium bromide acts by blocking muscarinic receptors, reducing vagal‑mediated bronchoconstriction. It should be co‑administered with albuterol for three doses in moderate to severe exacerbations[18]. After the first three treatments, ipratropium is discontinued because evidence does not support continued use beyond initial therapy[19].

Corticosteroids

Systemic corticosteroids reduce airway inflammation, decrease mucus production and upregulate beta₂‑receptors. Children with moderate to severe exacerbations should receive steroids as early as feasible[20]. A.G. receives oral dexamethasone 0.6 mg/kg. Oral dosing has been shown to be as effective as intravenous methylprednisolone with fewer side effects[21]. Prednisone or prednisolone are alternatives; the dosing regimen is 1–2 mg/kg/day for 3–5 days. Evidence indicates no need to taper a short course of oral steroids for acute exacerbation.

Magnesium Sulphate

Children with incomplete response after one hour of SABA and steroids may benefit from intravenous magnesium sulphate. Meta‑analyses show that magnesium sulphate improves respiratory function and reduces hospital admissions in moderate to severe exacerbations[22]. Because A.G. responds to initial therapy with improved PEF (70 % of baseline) and oxygen saturation >94 %, magnesium is not administered.

Other Therapies

Continuous nebulization of albuterol may be considered if symptoms worsen despite intermittent doses[23]. Non‑invasive ventilation can alleviate muscle fatigue in severe cases[24]. Heliox (a helium–oxygen mixture) may improve gas exchange in refractory attacks[24]. Epinephrine is reserved for suspected anaphylaxis[25]. Intravenous beta‑agonists, aminophylline or ketamine are third‑line therapies and require intensive care monitoring.

Ongoing Assessment and Monitoring

Nurses continuously evaluate respiratory effort, mental status and vital signs. Peak flow is measured every 20 minutes to assess response. Signs of impending respiratory failure silent chest, fatigue, altered level of consciousness, rising PaCO₂ warrant immediate escalation and potential intubation. Cardiac monitoring is important because beta₂‑agonists may cause tachycardia and arrhythmias[13]. Serum potassium is monitored due to risk of hypokalemia.

Psychosocial Support

Acute asthma attacks can be frightening. A.G. expresses fear of dying; anxiety may exacerbate dyspnea. The nurse provides calming reassurance, stays with the patient during nebulization and coaches him to slow his breathing. The mother is included in the process to reduce her anxiety and reinforce understanding of treatment. Emotional support reduces sympathetic activation and may improve the child’s respiratory pattern.

Transition to Long‑Term Control: Education and Self‑Management

Once the acute episode is stabilized, attention shifts to prevention of future exacerbations. Under the stepwise approach advocated by the EPR‑3 guidelines, controller medications are escalated or de-escalated based on severity[26].

Stepwise Pharmacotherapy

• Step 1 (Intermittent asthma): Use of a short‑acting beta₂‑agonist as needed for symptom relief[27].
• Step 2 (Mild persistent): A low‑dose inhaled corticosteroid (ICS) is the preferred long‑term controller; montelukast is an alternative[28].
• Step 3 (Moderate persistent): For children 0–4 years, a medium‑dose ICS is recommended; for those aged 5–11 years, either a medium‑dose ICS or a combination of low‑dose ICS and a long‑acting beta₂‑agonist (LABA) or leukotriene receptor antagonist can be used[29]. In adolescents and adults, combination therapy with low‑dose ICS plus LABA is preferred.
• Step 4: Medium‑dose ICS plus LABA or montelukast in young children; medium‑dose ICS plus LABA in older children and adolescents[30].
• Step 5: High‑dose ICS plus LABA or montelukast for all age groups; consider biologic therapy (omalizumab) for allergic asthma[31].
• Step 6: High‑dose ICS plus LABA with oral systemic corticosteroids; referral to an asthma specialist and evaluation for biologics[32].

Stepping up therapy is indicated when asthma remains uncontrolled despite adherence, proper inhaler technique and removal of modifiable triggers. Stepping down is considered after maintaining good control for three to six months. The case study provides an opportunity to practice adjusting therapy based on guidelines and patient response.

Inhaler Technique and Adherence

Many children misuse their inhalers, reducing medication deposition in the lungs. Nurses must teach the correct technique using an age‑appropriate device and a spacer. A.G. and his mother practice using the MDI with a spacer; they are instructed to shake the inhaler, exhale fully, place the mouthpiece in his mouth, press the canister and inhale slowly and deeply, then hold the breath for 10 seconds before exhaling. The nurse emphasises the importance of daily controller medication even when asymptomatic, using a sticker chart to encourage adherence. The mother is educated about obtaining refills and not stopping the inhaler prematurely.

Asthma Action Plan

An individualized asthma action plan is developed in collaboration with the family. These plans divide management into zones: Green (well controlled), Yellow (worsening symptoms) and Red (severe exacerbation). Each zone lists symptoms, peak flow ranges, medication instructions and when to seek medical help. EPR‑3 guidelines recommend that all patients have an action plan[33]. A.G.’s plan includes daily budesonide 200 mcg twice daily (Step 2), SABA use as needed for relief, and instructions to increase controller dosage or seek medical attention for persistent symptoms. The plan is shared with the school nurse and kept at home.

Environmental Control and Trigger Avoidance

Identifying and controlling triggers are essential for long‑term management. The nurse reviews potential triggers with A.G. and his mother:

• Allergens: Dust mites (encourage mattress and pillow covers, weekly hot‑water washing of bedding), pet dander (consider limiting exposure), molds (repair leaks and clean moldy surfaces), cockroaches (pest control).
• Air pollutants: Avoid second‑hand tobacco smoke; do not allow smoking in the home.
• Viral infections: Encourage hand hygiene and influenza vaccination; continue to monitor after colds.
• Exercise: Use a SABA 15 minutes before vigorous activity; ensure warm‑up and cool‑down.
• Weather changes: In cold weather, use a scarf over the nose and mouth; maintain indoor humidity.

Diet and Weight Management

Obesity exacerbates asthma symptoms and reduces medication responsiveness. The nurse assesses A.G.’s body mass index (BMI) and provides guidance on balanced nutrition, physical activity, and limiting sugary drinks. Consuming a diet rich in fruits, vegetables and omega‑3 fatty acids may reduce airway inflammation. The family is connected with a nutritionist for further support.

Psychosocial and Cultural Considerations

Asthma management in children must consider family beliefs, cultural practices and health literacy. The nurse uses plain language, demonstration and the teach‑back method to ensure comprehension. Given the mother’s employment schedule, the nurse discusses setting reminders and integrating medication administration into daily routines. They address concerns about steroid side effects and emphasize the benefits of adherence. Because the family has limited resources, the social worker assists with insurance coverage for medications and home modifications.

Follow‑Up and Continuity of Care

Fragmentation of care is a recognized barrier in pediatric asthma management[2]. To ensure continuity, the nurse schedules a follow‑up appointment with the primary care provider within two weeks. The plan includes routine visits every three months, or sooner if control deteriorates. The case study underscores the need for multidisciplinary collaboration: the pediatrician, nurse, respiratory therapist, school nurse and social worker all contribute to long‑term control. Shared decision‑making is encouraged to enhance adherence and empower A.G. and his family[2].

Discussion

This pediatric asthma case study illustrates the complexities of managing acute exacerbations while planning for long‑term control. A.G.’s presentation highlights common challenges: poor adherence to controller medication, inadequate follow‑up and exposure to environmental triggers. The acute management followed evidence‑based guidelines: rapid assessment; oxygen supplementation when saturation dropped below 92 %; administration of inhaled beta₂‑agonists and ipratropium; and timely initiation of systemic corticosteroids[34]. A.G. improved after three nebulized treatments and a single dose of dexamethasone, avoiding intravenous magnesium sulphate. Continuous monitoring ensured early recognition of complications. Psychosocial support alleviated anxiety, an often under‑recognized component of asthma care.

The transition to long‑term management emphasized the stepwise pharmacologic approach. Inhaled corticosteroids remain the foundation of controller therapy at all steps beyond intermittent asthma[35]. Combining an inhaled corticosteroid with a LABA or leukotriene receptor antagonist is recommended for children with moderate to severe persistent asthma[29]. Biologic therapies such as omalizumab are now available for allergic asthma unresponsive to conventional therapy[31]. However, medication alone cannot achieve control. Education on inhaler technique, adherence, trigger avoidance and self‑monitoring is critical. The case underscores how knowledge deficits and socio‑economic barriers lead to poor adherence; targeted education and social support can mitigate these issues.

The case study also reflects systemic challenges. Qualitative research has shown that pediatric asthma care is often fragmented, with GPs prioritizing acute symptom management and underestimating chronic care[2]. A lack of structured follow‑up contributes to insufficient self‑management skills[2]. Nurses play a pivotal role in bridging these gaps by coordinating follow‑up, facilitating communication among healthcare providers and advocating for integrated care. Shared decision‑making enhances adherence and empowers families to take ownership of asthma control[2]. Addressing social determinants housing quality, air pollution, poverty requires broader public health interventions.

Finally, the case highlights the psychological impact of asthma. Anxiety and fear can exacerbate symptoms and hinder adherence. Nurses must adopt a family‑centered approach, acknowledging emotional and cultural factors. Community resources, support groups and school nurse involvement can provide additional support.

Conclusion

A thorough pediatric asthma case study offers invaluable lessons for nursing practice. It reinforces the need for prompt, evidence‑based management of acute exacerbations, guided by reputable sources such as the Canadian Pediatric Society and StatPearls[34][26]. The stepwise approach to long‑term control underscores the central role of inhaled corticosteroids and emphasises tailored therapy based on severity and patient response[26]. Nurses must assess severity, administer appropriate medications, monitor response and anticipate complications. Equally important is education on inhaler technique, adherence and avoidance of triggers. Effective communication and shared decision‑making empower children and caregivers to manage asthma proactively.

Case‑based learning also exposes the systemic challenges inherent in pediatric asthma care, such as fragmentation of services and disparities linked to socio‑economic status. By coordinating follow‑up, facilitating multidisciplinary collaboration and addressing social determinants, nurses can help mitigate these barriers. Ultimately, an integrative approach combining pharmacologic therapy, education, psychosocial support and public health initiatives is vital for improving outcomes and quality of life for children with asthma.

Bibliography

StatPearls Publishing. Pediatric Asthma (Nursing). Treasure Island, FL: StatPearls Publishing, 2024. Accessed April 12, 2026. https://www.ncbi.nlm.nih.gov/books/NBK568735/.

Søndergaard, Jens, et al. “Improving Asthma Care in Children: Revealing Needs and Bottlenecks through In-Depth Interviews.” BMC Primary Care (2024). Accessed April 12, 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC11655526/.

Canadian Paediatric Society. “Managing an Acute Asthma Exacerbation in Children.” Canadian Paediatric Society. Accessed April 12, 2026. https://cps.ca/en/documents/position/managing-an-acute-asthma-exacerbation.

[1] [3] [4] [5] [6] [7] [8] [9] [10] [14] [18] [21] [24] [26] [27] [28] [29] [30] [31] [32] [33] [35] Pediatric Asthma (Nursing) – StatPearls – NCBI Bookshelf

https://www.ncbi.nlm.nih.gov/books/NBK568735/

[2]  Improving asthma care in children: revealing needs and bottlenecks through in-depth interviews – PMC 

https://pmc.ncbi.nlm.nih.gov/articles/PMC11655526/

[11] [12] [13] [15] [16] [17] [19] [20] [22] [23] [25] [34] Managing an acute asthma exacerbation in children | Canadian Paediatric Society

https://cps.ca/en/documents/position/managing-an-acute-asthma-exacerbation